Questions and Answers on USP 797
-
RJLG Question 5: I
read somewhere in the USP 797 that it was acceptable
to mix a low volume of chemotherapy agents without a
separate negative pressure room as long as CSTD's were
used. Is this correct? Also--what is considered a
low volume?
-
RJLG Answer 5:
When a closed system
transfer device (CSTD) is used within the ISO Class 5
biological safety cabinet (BSC) or compounding aseptic
containment isolator (CACI) for low volume hazardous
drug preparation only, a non-negative pressure room is
acceptable provided other precautions and
recommendations are followed. For instance: all
hazardous drugs shall be separate from non-hazardous
drugs in storage (separate storage area) and handling
(dedicated BSC or CACI); the BSC or CACI shall be
placed in a restricted access ISO Class 7 non-negative
pressure buffer area, or a CACI may be used outside of
the ISO Class 7 buffer area provided it is in a
restricted access room that meets the conditions in
the section of USP<797> entitled Placement of Primary
Engineering Controls; proper procedures, training, and
personal protective equipment (PPE) are employed; and
containment should be verified by routine monitoring.
The Hazardous Drugs as CSPs section of USP<797> does
not describe low volume. Our interpretation is, if
the use of a CACI (100% vented glovebox) or two tiers
of containment (CSTD within a CACI or BSC) will allow
for the ability to handle the total peak volume of
hazardous drugs at the given facility without
compromising safety, sterility, quality, or workflow,
then the non-negative pressure room is acceptable as
described above.
Answer provided as a courtesty to usp797.org, inc. by RJ Lee
Group, Inc. (RJLG) and/or associates of RJLG. We assume
no liability for the use or interpretation of this
information. Please note that usp797.org, inc. is not
responsible for this answer.
-
Matthew
Zock is an industrial hygienist with the technical
consulting services group at RJ Lee Group, Inc. Mr. Zock
provides a variety of industrial hygiene, health & safety,
and environmental consulting services for heath care,
general industry, and litigation support. He manages
RJLG's USP 797 services including environmental sampling
(microbial), hazardous drug monitoring, and facility
design and operation audits. Mr. Zock received his
Bachelors in Biology from Clarion University of
Pennsylvania, and his Masters in Environmental and
Occupational Health Sciences from Hunter College. He can
be reached as follows:
Matthew Zock
RJ Lee Group, Inc.
350 Fifth Avenue, Suite 5820
New York, NY 10118
(212)613-2709
mzock@rjlg.com
|